Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Gilead to acquire stake in cancer immunotherapy company Pionyr Immunotherapeutics Gilead Sciences has agreed to acquire a stake of 49.9% in California-based cancer immunotherapy company Pionyr Immunotherapeutics, for… bypharmanewsdailyJune 25, 2020
